ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag apoptosis disease medicine

Lighting Up Life in Real Time
Aileen Constans | Jun 9, 2002 | 2 min read
In recent years scientists have exploited the light-generating capability of luciferase in applications ranging from apoptosis detection to DNA quantitation. Now Alameda, Calif.-based Xenogen has taken this useful enzyme one step further, with a luciferase-based system for studying infectious diseases, cancer, and metabolic diseases in living animals in real time. Xenogen has developed Bioware™ animal models, in which pathogens, target genes, or tumor cells are tagged with luciferase, whi
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
Screening Whole
Kelly Rae Chi | Aug 1, 2009 | 7 min read
By Kelly Rae Chi Screening Whole How to reel in high-throughput results using worms and fish. In the past few years, improvements in imaging and automation techniques have made it easy for researchers to see hundreds of plates of cells partake in every activity from differentiation to apoptosis. But in living and breathing animals, we’re only just beginning to realize the potential of large-scale screens. “To take a whole animal and
Recourse to Death
Michael Brush | Aug 20, 2000 | 10 min read
Manufactureres of Flow Cytometry Products for Apoptosis Detection To examine the causes of life, we must first have recourse to death," uttered Victor Frankenstein upon beginning his search for the source from "whence the principle of life proceeds" and ultimately creating his nameless monster. Frankenstein's real creator, 19-year-old Mary Shelley, probably had no idea when Frankenstein was first published in 1816 that her main character's motivation would eventually have real-life implication
Revisiting Microarrays
Leonard Augenlicht | Oct 5, 2003 | 3 min read
Revisiting Microarrays Regarding the articles on microarrays,1-3 Pat Brown and the group at Stanford deserve great recognition for their technological innovations that led to widespread use of microarray analysis in biomedical research. However, the concept of computerized gene expression profiling, its reduction to practice, and enumeration of its potential in many areas of disease diagnosis, prognosis, drug sensitivity, and investigation of underlying mechanism has a much longer history.
Master of the Cell
Judy Lieberman | Apr 1, 2010 | 10+ min read
By Judy Lieberman Master of the Cell RNA interference, with its powerful promise of therapy for many diseases, may also act as a master regulator of most—if not all—cellular processes. RNA silencing. Computer artwork showing a length of RNA (yellow with red rings) bound to an RNA-induced silencing complex (RISC). © Medi-Mation Ltd / Photo Researchers, Inc. ne of the biggest surprises in biology in the past d
On the Chain Gang
Keith D. Wilkinson and David Fushman | Jul 1, 2012 | 10 min read
More than simply helping haul out a cell’s garbage, ubiquitin, with its panoply of chain lengths and shapes, marks and regulates many unrelated cellular processes.
A Small Revolution
Erica Westly | Oct 1, 2011 | 5 min read
In fewer than 15 years, nanomedicine has gone from fantasy to reality.
A Vaulted Mystery
Eufemia S. Putortì and Massimo P. Crippa | Aug 1, 2014 | 10+ min read
Nearly 30 years after the discovery of tiny barrel-shape structures called vaults, their natural functions remain elusive. Nevertheless, researchers are beginning to put these nanoparticles to work in biomedicine.
Mafia Wars
Jef Akst | May 31, 2010 | 10+ min read
An increasing amount of data is showing that the cellular battle between pathogens and hosts needs much more than a simple military metaphor to describe it—think undercover infiltration, front organizations, and forced suicide.

Run a Search

ADVERTISEMENT